Benjamin Pevestorf has a diverse work experience in the pharmaceutical industry. Benjamin worked at MorphoSys as a Senior Scientist and Team Lead for Physico- Chemical Analytics. In this role, they were responsible for physico-chemical analysis of NBEs, quality attribute assessment, formulation development, and analytical method development for drug products. Benjamin also led the development and formulation optimization of a subcutaneous highly concentrated liquid formulation (HCLF) for a monoclonal antibody. Additionally, they were involved in lyophilization process development and coordination of analytical studies.
Prior to MorphoSys, Benjamin worked at Coriolis Pharma as a Scientist specializing in lyophilization process development. Benjamin conducted stability studies, implemented good research practice systems, and supported process transfer and scale-up activities.
Furthermore, Benjamin has completed a Master's thesis at Boehringer Ingelheim and a Bachelor's thesis at Südzucker AG.
Benjamin Pevestorf completed their Master of Science (MSc) degree in Biotechnology from Hochschule Mannheim. Benjamin attended the university from 2009 to 2014.
May, 2023 - present
October, 2020